Viveve Medical (NASDAQ:VIVE) and Semler Scientific (OTCMKTS:SMLR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends and institutional ownership.
Insider and Institutional Ownership
59.8% of Viveve Medical shares are owned by institutional investors. Comparatively, 12.0% of Semler Scientific shares are owned by institutional investors. 5.9% of Viveve Medical shares are owned by insiders. Comparatively, 13.9% of Semler Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Viveve Medical has a beta of 0.25, meaning that its stock price is 75% less volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 0.46, meaning that its stock price is 54% less volatile than the S&P 500.
This is a breakdown of recent ratings for Viveve Medical and Semler Scientific, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Viveve Medical currently has a consensus price target of $3.50, suggesting a potential upside of 821.05%. Semler Scientific has a consensus price target of $44.00, suggesting a potential upside of 0.69%. Given Viveve Medical’s higher probable upside, analysts clearly believe Viveve Medical is more favorable than Semler Scientific.
Earnings and Valuation
This table compares Viveve Medical and Semler Scientific’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Viveve Medical||$18.52 million||0.95||-$49.32 million||($1.61)||-0.24|
|Semler Scientific||$21.49 million||13.14||$5.01 million||$0.66||66.21|
Semler Scientific has higher revenue and earnings than Viveve Medical. Viveve Medical is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.
This table compares Viveve Medical and Semler Scientific’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Semler Scientific beats Viveve Medical on 11 of the 14 factors compared between the two stocks.
About Viveve Medical
Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components. It markets its products through sales employees and distributors in the United States, the Asia Pacific, Europe, the Middle East, Latin America, and Canada. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
About Semler Scientific
Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. It offers its products through salespersons and distributors. Semler Scientific, Inc. was founded in 2007 and is headquartered in San Jose, California.
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.